Issued Patents All Time
Showing 25 most recent of 38 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12311010 | Formulated and/or co-formulated liposome compositions containing toll-like receptor(“TLR”) agonist prodrugs useful in the treatment of cancer and methods thereof | David Stover, Dhruba Bharali, Tahmineh Safaie | 2025-05-27 |
| 12286403 | Formulated and/or co-formulated liposome compositions containing IDO antagonist prodrugs useful in the treatment of cancer and methods thereof | David Stover, Dhruba Bharali, Tahmineh Safaie | 2025-04-29 |
| 12213468 | Population control using engineered translocations | Omar S. Akbari, Anna B. Buchman | 2025-02-04 |
| 12157883 | DNA sequence modification-based gene drive | Georg Oberhofer, Tobin William Ivy | 2024-12-03 |
| 12059470 | Formulated and/or co-formulated liposome compositions containing PD-1 antagonist prodrugs useful in the treatment of cancer and methods thereof | David Stover, Dhruba Bharali, Tahmineh Safaie | 2024-08-13 |
| 11965172 | DNA sequence modification-based gene drive | Georg Oberhofer, Tobin William Ivy | 2024-04-23 |
| 11896646 | Formulated and/or co-formulated liposome compositions containing toll-like receptor (“TLR”) agonist prodrugs useful in the treatment of cancer and methods thereof | David Stover, Dhruba Bharali, Tahmineh Safaie | 2024-02-13 |
| 11833209 | Formulated and/or co-formulated liposome compositions containing PD-1 antagonist prodrugs useful in the treatment of cancer and methods thereof | David Stover, Dhruba Bharali, Tahmineh Safaie | 2023-12-05 |
| 11801304 | Formulated and/or co-formulated liposome compositions containing TFGB antagonist prodrugs useful in the treatment of cancer and methods thereof | David Stover, Dhruba Bharali, Tahmineh Safaie | 2023-10-31 |
| 11744874 | Formulated and/or co-formulated liposome compositions containing toll-like receptor (“TLR”) agonist prodrugs useful in the treatment of cancer and methods thereof | David Stover, Dhruba Bharali, Tahmineh Safaie | 2023-09-05 |
| 11723888 | Polymer conjugated thyrointegrin antagonists | Shaker A. Mousa, Ozlem O. Karakus | 2023-08-15 |
| 11679141 | Formulated and/or co-formulated liposome compositions containing toll-like receptor (“TLR”) agonist prodrugs useful in the treatment of cancer and methods thereof | David Stover, Dhruba Bharali, Tahmineh Safaie | 2023-06-20 |
| 11186551 | Composition of scalable thyrointegrin antagonists with improved retention in tumors | Shaker A. Mousa | 2021-11-30 |
| 10966414 | Population control using engineered translocations | Omar S. Akbari, Anna B. Buchman | 2021-04-06 |
| 10961204 | Composition of scalable thyrointegrin antagonists with improved blood brain barrier penetration and retention into brain tumors | Shaker A. Mousa | 2021-03-30 |
| 10570200 | Antibody-mediated immunocontraception | Juan Li | 2020-02-25 |
| 10450345 | Method of isolation of polypeptide-aptamer-polymer conjugates | Erik Leeming Kvam, Ernest William Kovacs | 2019-10-22 |
| 9846206 | Systems and methods for magnetic material imaging | Dominic Michael Graziani, Thomas Kwok-Fah Foo, Luca Marinelli, Daniel Eugene Meyer | 2017-12-19 |
| 9827335 | Treating water insoluble nanoparticles with hydrophilic alpha-hydroxyphosphonic acid conjugates, the so modified nanoparticles and their use as contrast agents | Brian Christopher Bales, Binil Itty Ipe Kandapallil | 2017-11-28 |
| 9474810 | Superparamagnetic nanoparticles with PEG substituted α-hydroxy phosphonate shells | Daniel Eugene Meyer, Brian Christopher Bales, Michael Todd Luttrell | 2016-10-25 |
| 9468693 | Labeled molecular imaging agents and methods of use | Jack Mathew Webster | 2016-10-18 |
| 9468692 | Labeled molecular imaging agents and methods of use | Jack Mathew Webster | 2016-10-18 |
| 9399075 | Nanoparticle contrast agents for diagnostic imaging | Matthew David Butts, Robert Edgar Colborn, Peter John Bonitatibus, Jr., Andrew Soliz Torres, Brian Christopher Bales +2 more | 2016-07-26 |
| 9251937 | Heat stable nanoparticle preparations and associated methods thereof | Brian Christopher Bales, Brian James Grimmond, Daniel Eugene Meyer, Michael Todd Luttrell | 2016-02-02 |
| 9205155 | Treating water insoluble nanoparticles with hydrophilic alpha-hydroxyphosphonic acid conjugates, the so modified nanoparticles and their use as contrast agents | Brian Christopher Bales, Binil Itty Ipe Kandapallil | 2015-12-08 |